Cutaneous T-cell lymphoma (CTCL) is a heterogeneous malignancy characterized by the proliferation of skin-homing CD4+ T cells and profound immune dysregulation within the tumor microenvironment (TME). This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.